The risk in selling reduced-nicotine cigarettes
On Friday the 28th of July, the U.S. Food and Drug Administration (FDA), announced a new comprehensive plan for tobacco and nicotine regulation, which included lowering the amount of nicotine in cigarettes in order to minimize addiction.
Similarly, article 20 of the European Tobacco Products Directive (EU-TPD</div><div class=glossaryItemBody>The Tobacco Product Directive (TPD) is the legal framework proposed by the European Committee ENVI to regulate tobacco products and its derivatives in Europe. Because it may contain nicotine and mimics the act of smoking, the electronic cigarette, falls in this Directive.</div>”>TPD), limited the nicotine level in e-cigarettes to 20 mg/mL, and this regulation is thought to be possibly having negative consequences on seasoned vapers.
VLNCs : less nicotine but same amount of carcinogens as regular cigs
In order to obtain the level of nicotine they were accustomed to, vapers forced to switch to lower concentrations of nicotine tend to puff more frequently and intensely, and hence increase the inhalation of harmful compounds. Sadly, the same is expected to happen when seasoned smokers are forced to switch to low-nicotine cigarettes.
VLNCs (very low nicotine cigarettes), will contain nicotine at levels that do not produce physiological effects, therefore will be delivering the same amount of harmful chemicals without the benefits perceived by the smoker.
Dr. Nancy Kass from Johns Hopkins University is posing some important questions and believes that serious considerations need to be made before VLNCs are accepted as the ideal solution to minimize smoking.
Research required on the effect of VLNC’s on smokers unwilling to quit
In an article on The Hill, Dr. Carrie Wade, a harm reduction policy manager for the R Street Institute, said that a more detailed analysis suggests that smokers given VLNCs do in fact smoke less and report fewer cravings, therefore low nicotine cigarettes may help in the smoking cessation process amongst those wishing to quit.
However, she added, there isn’t enough data available on their effect on those who have no intention of quitting. Therefore, the products may be effective for smoking cessation, and may prevent adolescents experimenting with cigarettes from becoming addicted to smoking. However, they may have adverse effects on seasoned smokers who have no intention of quitting. “Reducing the nicotine content fundamentally changes cigarettes to literal ‘cancer sticks’,” said Wade.
“Before those in both the tobacco control and tobacco harm reduction communities advocate for such a drastic shift in the tobacco landscape, it is imperative that we first consider the ethics of VLNCs.” she concluded.
From: Vaping Post